title: Rosiglitazone: failure of oversight or demons imagined?
authors.forename: Jeff
authors.initials: J
authors.lastname: Susman
mesh_terms: D002986:Clinical Trials as Topic; D003376:Counseling; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000209:etiology; D010817:Physician-Patient Relations; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone